Nomura Holdings, Inc.
NMR · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 0.22 | -0.48 | -1.61 |
| FCF Yield | -31.87% | -0.47% | -57.10% | -61.94% |
| EV / EBITDA | 53.52 | 85.35 | 109.76 | 30.89 |
| Quality | ||||
| ROIC | 0.86% | 0.44% | 0.28% | 0.72% |
| Gross Margin | 36.89% | 34.68% | 49.87% | 83.25% |
| Cash Conversion Ratio | -1.95 | 0.75 | -7.58 | -5.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 25.20% | 42.48% | 17.53% | -7.53% |
| Free Cash Flow Growth | -6,508.20% | 98.48% | 11.10% | -278.45% |
| Safety | ||||
| Net Debt / EBITDA | 48.41 | 76.99 | 102.57 | 25.39 |
| Interest Coverage | 0.17 | 0.11 | 0.13 | 0.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.03 |
| Cash Conversion Cycle | -43.83 | -29.70 | -193.38 | 11,743.15 |